Physician profile
Lori A Baxter
NPI 1669416921
$2,418.63
in general payments reported to CMS, 2019-2025
16 companies · $384 in 2025
The $384 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $195 · 2021: $359 · 2022: $276 · 2023: $167 · 2024: $676 · 2025: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $505.64 | 2019-2024 | Jornay Pm |
| Corium, LLC | $496.82 | 2022-2025 | Azstarys |
| Pfizer INC. | $272.91 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $263.26 | 2021-2024 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $164.64 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $148.69 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.83 | 2019-2022 | |
| Novo Nordisk INC | $98.15 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $91.75 | 2020-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Tris Pharma INC | $89.73 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Adlon Therapeutics L.P. | $66.42 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $38.53 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $24.95 | 2024 | Daybue |
| Genentech USA, INC. | $19.95 | 2020 | |
| Cranial Technologies, INC | $18.79 | 2025 | Doc Band |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.57 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.